The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Schellenberg Wittmer Ltd

Offices

  • Geneva
  • Singapore

Other ranked firms

The following firms have provided more information to help you choose the right firm.


Switzerland

Banking and finance: Geneva

Oberson Abels Ltd

Walder Wyss

Python

Baker McKenzie

Meyerlustenberger Lachenal Ltd

Froriep

Mangeat Attorneys at Law LLC

Gillioz Dorsaz & Associés

Banking and finance: Zurich

Froriep

CMS

Wenger & Vieli

VISCHER

Meyerlustenberger Lachenal Ltd (MLL)

Capital markets

Prager Dreifuss AG

Bratschi Ltd

Commercial, corporate and M&A

Python

Thouvenin Rechtsanwälte

Froriep

Eversheds Sutherland AG

Bratschi Ltd

id est avocats sàrl

BianchiSchwald LLC

CMS

Loyens & Loeff

Competition

Kellerhals Carrard

Pestalozzi

Dispute resolution: arbitration

Walder Wyss Ltd

Niederer Kraft Frey

Dispute resolution: litigation

CMS

VISCHER

LALIVE

Employment

Gillioz Dorsaz & Associés

MME – Legal | Tax | Compliance

Bratschi Ltd

Thouvenin Rechtsanwälte

Healthcare and life sciences

CMS

Homburger

Bär & Karrer Ltd.

VISCHER

Insolvency and corporate recovery

Bär & Karrer Ltd.

Lenz & Staehelin

Pestalozzi

Prager Dreifuss AG

Kellerhals Carrard

Baker McKenzie

Insurance

Bär & Karrer Ltd.

Lenz & Staehelin

VISCHER

Intellectual property

Pestalozzi

VISCHER

Bär & Karrer Ltd.

BianchiSchwald LLC

Niederer Kraft Frey

Leading firms: French-speaking Switzerland

Bär & Karrer Ltd.

Walder Wyss

Leading firms: German-speaking Switzerland

Kellerhals Carrard

Meyerlustenberger Lachenal Ltd (MLL)

CMS

Wenger & Vieli

Private client

Meyerlustenberger Lachenal Ltd (MLL)

Baker McKenzie

Public law

Bratschi Ltd

Homburger

Real estate and construction

Python

Pestalozzi

VISCHER

Homburger

BianchiSchwald LLC

Sports law

Homburger

Bratschi Ltd

Froriep

TMT

Thouvenin Rechtsanwälte

Froriep

Kellerhals Carrard

Pestalozzi

Tax

ADB Altorfer Duss & Beilstein

Python

Loyens & Loeff

Ludwig + Partner Ltd.

Prager Dreifuss AG

VISCHER

MME – Legal | Tax | Compliance

FBT Attorneys-at-Law

Froriep

Transport

VISCHER


Legal Developments in Switzerland

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to
  • Ordinance on Integrity and Transparency in the Therapeutic Products Sector has been adopted

    Click here for more information.
  • Bär & Karrer Advises B3i in its Current Equity Funding Round

    Industry-led InsurTech B3i Services AG successfully raised additional funds from current shareholders and new investors to further develop and grow its blockchain-based insurance transaction platform. B3i was founded in October 2016 as an insurance industry consortium which then formed B3i Services AG as an independent company. The shareholder group includes some of the world's largest insurers and reinsurers from across Europe, the Americas, and Asia. B3i intends to further expand its shareholder base over the next several months.
  • Bär & Karrer Continues to Grow Finance and Sports Practice with Two New Partners

    Bär & Karrer is pleased to announce that it further strengthens its Financing and Sports practices with new partners Lukas Roesler and Dr. Jan Kleiner, both of whom have worked with the firm previously.
  • Bär & Karrer Advises Novartis and Alcon on the Spin-off of Alcon

    Today, Novartis AG completed the spin-off of the Alcon eye care devices business, and Alcon Inc. debuted as independent publicly traded company. The Alcon shares were successfully listed on the SIX Swiss Exchange Ltd. and the New York Stock Exchange. They are also included in the Swiss Market Index (SMI), which comprises the 20 largest Swiss listed stocks.
  • Bär & Karrer Advises Primeo Energie and CSA Energie-Infrastructure Schweiz in Aquisition from Elét

    Primeo Energie, EOS Holding SA (EOS) and Électricité de France (EDF) have entered into a share purchase agreement relating to the purchase by Primeo Energie and EOS of the 25% interest held by EDF in Alpiq Holding SA. The purchase by Primeo Eergie and EOS will be financed through mandatory exchangeable loan agreements made by CSA Energie-Infrastruktur Schweiz (CSA) as lender, the biggest investment pool for Swiss energy infrastructure with 135 Swiss pension funds acting as investors. At maturity the mandatory exchangeable loan agreements will be converted into shares in Alpiq. Primeo Energie and EOS thereby pave the way for a Swiss shareholder structure of Alpiq.
  • Bär & Karrer Awarded Most Innovative Swiss Law Firm of the Year at the IFLR Europe Awards

    Bär & Karrer was awarded „Most innovative law firm of the year - Switzerland", the national award for Switzerland given in the IFLR European Awards. The most innovative law firm of the year award recognizes Bär & Karrer as the Swiss law firm with the best track record in 2018 giving advice on the most innovative cross-border deals covering all award practice areas. It is already the third prize of this kind in period of six years awarded to Bär & Karrer.
  • Bär & Karrer Advises DSV on Public Exchange Offer for Panalpina

    On 1 April 2019, DSV A/S, Hedehusene, Denmark and Panalpina Welttransport (Holding) AG, Zurich, Switzerland, have entered into an agreement on the terms and conditions of a combination by way of a public exchange offer by DSV for all publicly held registered shares of Panalpina for approximately CHF 4.6 billion. The board of directors of Panalpina has resolved to support the public exchange offer by DSV and to recommend the acceptance of DSV's public exchange offer to its shareholders.
  • Bär & Karrer Advises Lonza on the Entering into a Strategic Joint Venture with Chr. Hansen for Deve

    On 2 April 2019, Lonza, a leading pharma contract manufacturing company, and Chr. Hansen, a leading global bioscience company, announced that they have signed an agreement to establish a 50/50 joint venture to pioneer the live biotherapeutic products (LBPs) industry and position themselves as the leading contract development and manufacturing partner (CDMO) for biotech and pharma customers. The joint venture brings together best-in-class, complementary capabilities and will be the first CDMO globally to provide a full supply chain that offers manufacturing of bacteria strains for therapeutic use. The joint venture will be a 50/50 controlled legal entity that will operate from its headquarters in Basel (CH) and have production facilities in Denmark and Switzerland. A phased investment of approximately EUR 90 million will be deployed over three years to build cGMP-compliant pharma production capabilities. The joint venture will upgrade existing facilities in Hørsholm (DK) and equip new facilities in Basel (CH) to serve pre-clinical to phase II projects. Further facilities for phase III and commercial manufacturing will be developed as the pipeline matures. The joint venture is expected to be largely self-funding after the production set-up has been established.
  • Bär & Karrer Advises Computacenter in the Acquisition of PathWorks

    Computacenter Group, a leading European IT service provider listed on the London Stock Exchange, acquired PathWorks, a well-established hardware reseller in the Swiss market.
  • Bär & Karrer Advises Addtech in the Acquisition of a Majority in Omni Ray

    Addtech Group, a leading Swedish publicly listed technology trading group, acquired a majority stake in Omni Ray AG, a well-established Swiss trading company and service provider for automation solutions, mainly focused on industrial applications, infrastructure, transportation and medical industry. By this transaction, Addtech aims at strengthening its position in the European automation market.